CED DigestMarch 11, 2026. 230 items curated for clinical relevance. Above Threshold #97Alabama Medical Cannabis Sales Gear for Spring 2026 Launch# Summary Alabama's medical cannabis program is preparing to launch retail sales...
Policy Watch: 20 Regulatory Updates โ March 11, 2026
Policy WatchMarch 11, 2026. 20 regulatory items above the clinical relevance threshold of 40. Sources include Federal Register, regulations.gov, and regulatory RSS feeds. Listed in descending order of relevance score. Score 70Regulations.govSchedules...
Cannabinoid Clinical Trials: CBD Cortical Excitability Study
Clinical Takeaway In this randomized controlled trial of healthy males, CBD at both low (30 mg) and high (700 mg) single doses showed no direct effect on cortical excitability compared to placebo,...
Cannabinoid Clinical Trials: EEG Sleep Insomnia RCT
Clinical Takeaway In this small pilot trial, a single oral dose of 10 mg THC combined with 200 mg CBD reduced total sleep time by approximately 25 minutes in adults with diagnosed...
`Endocannabinoid System Research: Cannabis for Anxiety`
Clinical Takeaway Cannabis use for anxiety shows meaningful differences depending on whether someone uses flower or edible products, with daily and longer-term reductions in anxiety varying by product type and cannabinoid composition....
`Cannabinoid Clinical Trials: CBD for Fibromyalgia`
Clinical Takeaway In this randomized, double-blind, placebo-controlled trial, CBD did not demonstrate superiority over placebo in reducing pain among patients with fibromyalgia. These findings highlight the current lack of robust clinical evidence...
endocannabinoid system clinical research: REAL 2.0 Study
Clinical Takeaway The REAL 2.0 study tracked Canadian youth for 15 years to examine how adolescent risk factors like body image concerns and disordered eating contribute to eating disorders, mental health conditions,...
Cannabinoid Clinical Trials: PTSD and Substance Use Disorders
Clinical Takeaway People with PTSD and co-occurring substance use disorders who use cannabis can still benefit meaningfully from trauma-focused treatments, and cannabis use does not appear to undermine treatment outcomes compared to...
endocannabinoid system clinical research: Mobile Mental Health RCT
Clinical Takeaway A randomized controlled trial tested the Minder mobile app, co-developed with university students, for improving mental health and substance use outcomes in a general college population. The study evaluated whether...
Endocannabinoid System Research in Athlete Mental Health
Clinical Takeaway Retired professional athletes from high contact team sports show elevated rates of depression, anxiety, and cognitive concerns compared to the general population, with career-related factors like concussion history and abrupt...